【目的】克隆鸡含溴结构域蛋白2(BRD2)基因及其剪接体,并对其进行序列分析和亚细胞定位,为深入研究鸡BRD2基因及其剪接体在细胞转录调控中的作用机理打下基础。【方法】通过RT-PCR扩增鸡BRD2基因及其剪接体的编码区(CDS)序列,采用BioEdi...【目的】克隆鸡含溴结构域蛋白2(BRD2)基因及其剪接体,并对其进行序列分析和亚细胞定位,为深入研究鸡BRD2基因及其剪接体在细胞转录调控中的作用机理打下基础。【方法】通过RT-PCR扩增鸡BRD2基因及其剪接体的编码区(CDS)序列,采用BioEdit、ProtParam、SOPMA、SWISS-MODEL、CDART等在线软件进行生物信息学分析;鸡BRD2基因及其剪接体经Xho I和Bam H I双酶切后,分别亚克隆至真核表达载体pEGFP-C1多克隆位点上构建重组真核表达载体,通过转染HEK-293T细胞进行亚细胞定位分析。【结果】鸡BRD2基因CDS序列全长2340 bp,编码779个氨基酸残基,分子量为85.66 k D,理论等电点(pI)为8.74,其编码蛋白二级结构主要由无规则卷曲(60.59%)和α-螺旋(28.50%)组成,含有3个明显的功能结构域(2个BD结构域和1个ET结构域)。与鸡BRD2基因相比,其剪接体BRD2-X1、BRD2-X2和BRD2-X3的CDS序列长分别为2301、2283和1983 bp,编码766、760和660个氨基酸残基。以鸡BRD2氨基酸序列为参照,BRD2-X1表现为第526~537位氨基酸缺失,BRD2-X2表现为第1~19位氨基酸缺失,BRD2-X3表现为第1~119位氨基酸缺失;与鸡BRD2蛋白相比,鸡BRD2基因剪接体BRD2-X1和BRD2-X2并未影响鸡BRD2蛋白的功能结构域,而剪接体BRD2-X3导致鸡BRD2蛋白第一个BD结构域部分缺失。鸡BRD2基因融合蛋白EGFP-BRD2及其剪接体融合蛋白EGFP-BRD2-X1、EGFP-BRD2-X2和EGFP-BRD2-X3均定位在细胞核,EGFP-BRD2和EGFPBRD2-X1在细胞核中呈均匀分布,而EGFP-BRD2-X2和EGFP-BRD2-X3在细胞核中呈不均匀的点状分布。【结论】鸡BRD2蛋白及其剪接体均定位在细胞核,但BD结构域缺失可引起BRD2剪接体BRD2-X3细胞核定位模式的变化。展开更多
Alzheimer disease(AD) has now become the most common brain disorder among the older population. In addition, the currently existing therapeutics only offer temporary symptomatic relieves. Therefore, further research a...Alzheimer disease(AD) has now become the most common brain disorder among the older population. In addition, the currently existing therapeutics only offer temporary symptomatic relieves. Therefore, further research and development of more efficacious and disease-modifying agents for the prevention, treatment and restoration of AD will have tremendous value from both scientific, and economic standpoints. Over the past few years, our series of studies have identified several highly promising anti-AD dimeric leads, with disease-modifying potentials. In this presentation, the latest progress on the neuroprotective and disease modifying effects and the underlying mechanisms of those candidates will be comprehensively illustrated and discussed.展开更多
OBJECTIVE Alzheimer disease(AD)is a leading cause of dementia in elderly individuals and therapeutic options for AD are very limited.Over-activation of N-methyl-D-aspar⁃tate(NMDA)receptors,amyloidβ(Aβ)aggrega⁃tion,a...OBJECTIVE Alzheimer disease(AD)is a leading cause of dementia in elderly individuals and therapeutic options for AD are very limited.Over-activation of N-methyl-D-aspar⁃tate(NMDA)receptors,amyloidβ(Aβ)aggrega⁃tion,a decrease in cerebral blood flow(CBF),and downstream pathological events play impor⁃tant roles in the disease progression of AD.This study seeks to explore the efficacy and mecha⁃nism of action of MN-08,a novel memantine ni⁃trate,in established animal models of AD.METHODS MN-08′s effectiveness as a preventative and therapeutic agent was tested in 2-to 8-month-old APP/PS1 transgenic mice and 9-to 12-month-old 3×Tg-AD mice,respectively.The neuroprotective mechanism of MN-08 was tested in the glutamate cell model.The pharmacokinet⁃ics and safety of MN-08 in vivo were determined in normal rats and beagle dogs.For the behavioral test,Western blotting analysis,pathology,ELISA test and in vitro cell tests,investigators were blinded to the experimental grouping and drug treatment.RESULTS MN-08,a novel meman⁃tine nitrate,was found to inhibit Aβaccumulation,prevent neuronal and dendritic spine loss,and consequently attenuate cognitive deficits in 2-month-old APP/PS1 transgenic mice(for a 6-month preventative course)and in the 8-month-old triple-transgenic(3×Tg-AD)mice(for a 4-month therapeutic course).In vitro,MN-08 could bind to and antagonize NMDA receptors,inhibit the calcium influx,and reverse the dysregula⁃tions of ERK and PI3K/Akt/GSK3βpathway,sub⁃sequently preventing glutamate-induced neuro⁃nal loss.In addition,MN-08 had favorable phar⁃macokinetics,blood-brain barrier penetration,and safety profiles in rats and beagle dogs.CON⁃CLUSION The novel memantine nitrate MN-08 may be a useful therapeutic agent for AD.展开更多
Zeolite-confined Fe-site catalysts(ZFCs)have emerged as superior materials for sustainably producing high-value chemicals through CO_(2) hydrogenation,owing to their adaptable framework,customizable composition,and th...Zeolite-confined Fe-site catalysts(ZFCs)have emerged as superior materials for sustainably producing high-value chemicals through CO_(2) hydrogenation,owing to their adaptable framework,customizable composition,and thermal robustness.They excel in activating,adsorbing,and converting CO_(2) with remarkable efficiency and consistency in performance.This has sparked a surge in research interest in recent years.The review delves into the latest advancements in CO_(2) catalytic hydrogenation to olefins,alcohols,aromatics,and other liquid hydrocarbons,examining the synthesis,modification tactics,and the correlation between structure and performance across various ZFCs.Additionally,it underscores the pivotal factors affecting performance and sheds light on the mechanisms behind selectivity control in the CO_(2) hydrogenation process facilitated by ZFCs.To conclude,it presents pressing challenges and strategic recommendations to inspire the development of high-performance,durable ZFCs for CO_(2) hydrogenation applications.展开更多
文摘【目的】克隆鸡含溴结构域蛋白2(BRD2)基因及其剪接体,并对其进行序列分析和亚细胞定位,为深入研究鸡BRD2基因及其剪接体在细胞转录调控中的作用机理打下基础。【方法】通过RT-PCR扩增鸡BRD2基因及其剪接体的编码区(CDS)序列,采用BioEdit、ProtParam、SOPMA、SWISS-MODEL、CDART等在线软件进行生物信息学分析;鸡BRD2基因及其剪接体经Xho I和Bam H I双酶切后,分别亚克隆至真核表达载体pEGFP-C1多克隆位点上构建重组真核表达载体,通过转染HEK-293T细胞进行亚细胞定位分析。【结果】鸡BRD2基因CDS序列全长2340 bp,编码779个氨基酸残基,分子量为85.66 k D,理论等电点(pI)为8.74,其编码蛋白二级结构主要由无规则卷曲(60.59%)和α-螺旋(28.50%)组成,含有3个明显的功能结构域(2个BD结构域和1个ET结构域)。与鸡BRD2基因相比,其剪接体BRD2-X1、BRD2-X2和BRD2-X3的CDS序列长分别为2301、2283和1983 bp,编码766、760和660个氨基酸残基。以鸡BRD2氨基酸序列为参照,BRD2-X1表现为第526~537位氨基酸缺失,BRD2-X2表现为第1~19位氨基酸缺失,BRD2-X3表现为第1~119位氨基酸缺失;与鸡BRD2蛋白相比,鸡BRD2基因剪接体BRD2-X1和BRD2-X2并未影响鸡BRD2蛋白的功能结构域,而剪接体BRD2-X3导致鸡BRD2蛋白第一个BD结构域部分缺失。鸡BRD2基因融合蛋白EGFP-BRD2及其剪接体融合蛋白EGFP-BRD2-X1、EGFP-BRD2-X2和EGFP-BRD2-X3均定位在细胞核,EGFP-BRD2和EGFPBRD2-X1在细胞核中呈均匀分布,而EGFP-BRD2-X2和EGFP-BRD2-X3在细胞核中呈不均匀的点状分布。【结论】鸡BRD2蛋白及其剪接体均定位在细胞核,但BD结构域缺失可引起BRD2剪接体BRD2-X3细胞核定位模式的变化。
文摘【目的】从鸡卵泡膜细胞蛋白中筛选和鉴定与膜联蛋白A2(ANXA2)相互作用的细胞蛋白并进行功能分析,为深入研究ANXA2调控鸡卵泡发育的作用机制提供理论依据。【方法】制备开产后30周龄贵州黄鸡的卵泡膜细胞,提取卵泡膜总蛋白后利用His Pull-Down联合质谱技术(LC-MS/MS)从卵泡膜细胞中筛选出与鸡ANXA2互作的细胞蛋白,然后通过GO数据库和KEEG数据库分别进行GO功能富集分析及KEEG信号通路注释分析,并利用STRING Version 11.0绘制蛋白互作网络图。【结果】通过His Pull-Down联合LC-MS/MS共鉴定获得41个鸡ANXA2互作细胞蛋白,GO功能富集分析发现这些互作细胞蛋白在分子功能、生物学进程和细胞组成均发挥作用。其中,在分子功能方面主要涉及蛋白结合(占58.06%)、催化活性(占19.35%)、核糖体结构(占16.13%)及细胞骨架结构组成(占6.45%),在生物学进程方面主要参与细胞骨架(占19.35%)、刺激反应(占19.35%)、翻译(占16.13%)、代谢过程(占12.90%)、细胞迁移(占12.90%)、蛋白折叠(占9.68%)和蛋白运输(占9.68%),而细胞组分显示以定位于细胞膜的蛋白为主(占32.26%)。鸡ANXA2蛋白互作细胞蛋白参与的KEEG信号通路主要有应激反应、代谢、翻译、信号转导、免疫系统和蛋白定位等。鸡ANXA2互作细胞蛋白互作网络可分为3条,即CNN2-FN1-MYH9-MYH10-ACTN1-CSRP1、ANXA1-ANXA2-ENO1-PRDX4-GPI-ATP5B-PRDX3-HSPA8-TUBB2A和CCT7-CCT4-GNB2L1-ATP5A1-RPS3-RPS3A-RPL23A-RPL22-RPS7;互作细胞蛋白间存在复杂的互作关系,其中又以膜联蛋白A1(ANXA1)与烯醇化酶-1(ENO1)及ANXA2的互作关系最明显。【结论】鸡ANXA2互作细胞蛋白主要参与细胞骨架形成、应对刺激和翻译等生物学过程,涉及应激反应、代谢、翻译、信号转导、免疫及蛋白定位等信号通路。其中,PRDX3、PRDX4、MYH9和TCSC可能通过与ANXA2蛋白相互作用而参与鸡卵巢相关疾病的发生,而ANXA1与ANXA2相互作用可能在鸡卵泡的发育及排卵过程中发挥重要调节作用。
基金Poly U(G-YBGQ G-SB81+3 种基金 G-YZ95)the Research Grant Council of Hong Kong(15101014)ITSP-Guangdong-Hong Kong Technology Cooperation Funding Scheme(GHP/012/16GD)Shenzhen Basic Research Program(JCYJ20160331141459373)
文摘Alzheimer disease(AD) has now become the most common brain disorder among the older population. In addition, the currently existing therapeutics only offer temporary symptomatic relieves. Therefore, further research and development of more efficacious and disease-modifying agents for the prevention, treatment and restoration of AD will have tremendous value from both scientific, and economic standpoints. Over the past few years, our series of studies have identified several highly promising anti-AD dimeric leads, with disease-modifying potentials. In this presentation, the latest progress on the neuroprotective and disease modifying effects and the underlying mechanisms of those candidates will be comprehensively illustrated and discussed.
文摘OBJECTIVE Alzheimer disease(AD)is a leading cause of dementia in elderly individuals and therapeutic options for AD are very limited.Over-activation of N-methyl-D-aspar⁃tate(NMDA)receptors,amyloidβ(Aβ)aggrega⁃tion,a decrease in cerebral blood flow(CBF),and downstream pathological events play impor⁃tant roles in the disease progression of AD.This study seeks to explore the efficacy and mecha⁃nism of action of MN-08,a novel memantine ni⁃trate,in established animal models of AD.METHODS MN-08′s effectiveness as a preventative and therapeutic agent was tested in 2-to 8-month-old APP/PS1 transgenic mice and 9-to 12-month-old 3×Tg-AD mice,respectively.The neuroprotective mechanism of MN-08 was tested in the glutamate cell model.The pharmacokinet⁃ics and safety of MN-08 in vivo were determined in normal rats and beagle dogs.For the behavioral test,Western blotting analysis,pathology,ELISA test and in vitro cell tests,investigators were blinded to the experimental grouping and drug treatment.RESULTS MN-08,a novel meman⁃tine nitrate,was found to inhibit Aβaccumulation,prevent neuronal and dendritic spine loss,and consequently attenuate cognitive deficits in 2-month-old APP/PS1 transgenic mice(for a 6-month preventative course)and in the 8-month-old triple-transgenic(3×Tg-AD)mice(for a 4-month therapeutic course).In vitro,MN-08 could bind to and antagonize NMDA receptors,inhibit the calcium influx,and reverse the dysregula⁃tions of ERK and PI3K/Akt/GSK3βpathway,sub⁃sequently preventing glutamate-induced neuro⁃nal loss.In addition,MN-08 had favorable phar⁃macokinetics,blood-brain barrier penetration,and safety profiles in rats and beagle dogs.CON⁃CLUSION The novel memantine nitrate MN-08 may be a useful therapeutic agent for AD.
基金the National Natural Science Foundation of China(Nos.U22A20107,U1967215,22078307,22208314,22278379,22238003,and 22002008)the Science and Technology R&D Program Joint Fund Project of Henan Provincial,China(No.222301420001)+3 种基金the Distinguished Young Scholars Innovation Team of Zhengzhou University,China(No.32320275)the Postgraduate Education Reform Project of Henan Province,China(No.2021SJGLX093Y)the National Funded Postdoctoral Researcher Program,China(No.GZC20232382)the Key Research Projects of University in Henan Province,China(No.24A150041).
文摘Zeolite-confined Fe-site catalysts(ZFCs)have emerged as superior materials for sustainably producing high-value chemicals through CO_(2) hydrogenation,owing to their adaptable framework,customizable composition,and thermal robustness.They excel in activating,adsorbing,and converting CO_(2) with remarkable efficiency and consistency in performance.This has sparked a surge in research interest in recent years.The review delves into the latest advancements in CO_(2) catalytic hydrogenation to olefins,alcohols,aromatics,and other liquid hydrocarbons,examining the synthesis,modification tactics,and the correlation between structure and performance across various ZFCs.Additionally,it underscores the pivotal factors affecting performance and sheds light on the mechanisms behind selectivity control in the CO_(2) hydrogenation process facilitated by ZFCs.To conclude,it presents pressing challenges and strategic recommendations to inspire the development of high-performance,durable ZFCs for CO_(2) hydrogenation applications.
